Which Bag on the Pole: Balanced Crystalloid or Saline for Early Septic Shock
A single patient, minutes into septic shock resuscitation. The disagreement is whether the specific crystalloid hanging on the pole meaningfully changes her odds of kidney injury, or whether that question has already been answered more ambiguously than either side wants to admit.
A.F., a 29-year-old elementary school teacher, gave birth to her first child eight days ago and had just begun to feel like herself again — back to grading a stack of end-of-year projects from her couch, she told the triage nurse, when the fever and lower abdominal pain started this afternoon. Her delivery itself was unremarkable, vaginal, no prolonged rupture of membranes, and she has no chronic medical history of any kind — the kind of unremarkable obstetric course that makes today's presentation land as a genuine complication rather than an expected one. Postpartum endometritis was suspected within the first twenty minutes of her arrival and confirmed on exam; by the time the resuscitation team reached her bedside, she was tachycardic to 128, hypotensive at 78/48, and visibly unwell in the specific way that makes a room move faster without anyone needing to say so.
The first liter of fluid is already running by the time the crystalloid question actually gets raised out loud — normal saline, because it was the nearest bag, not a deliberate choice — and what happens for the next several liters is genuinely still argued about. SMART, a large pragmatic trial in critically ill adults, found a modestly lower composite rate of death, new renal replacement therapy, or persistent renal dysfunction with balanced crystalloids compared to saline. But two subsequent large trials aimed at settling the question, BaSICS and PLUS, both found no significant difference in 90-day mortality between balanced solutions and saline in broader critically ill populations. She is young, previously entirely healthy, and her total resuscitation volume is likely to run into several liters over the next hours — the volume range where saline's chloride load and the resulting hyperchloremic acidosis is most plausibly relevant, even if the largest trials since SMART have not reproduced its mortality signal cleanly. What the literature actually supports, read honestly across all three trials rather than the first one alone, is closer to a real but unsettled question than a resolved one.
Resuscitation bay, deciding what fills the next bag
I want to switch to lactated Ringer's for everything from here forward. SMART found a real, if modest, reduction in the composite of death, new dialysis, or persistent kidney dysfunction with balanced solutions over saline in critically ill adults, and she is about to receive several liters — exactly the volume range where saline's chloride load plausibly matters most.
I want to be honest about what happened after SMART, because I do not think the evidence base stayed where that trial left it. BaSICS and PLUS, two much larger trials specifically designed to confirm SMART's signal, both found no significant 90-day mortality difference between balanced solutions and saline in broad critically ill populations. That does not mean SMART was wrong, but it does mean the field's honest current position is closer to unsettled than confirmed, and I would not want to overstate the strength of the case for switching.
I am not arguing for saline specifically — I am arguing against stating this more confidently than three trials in a row actually support.
Given genuine equipoise at the trial level, I would still lean balanced for her specifically, on mechanistic rather than trial-certainty grounds: large-volume saline resuscitation produces a real, measurable hyperchloremic acidosis, and there is physiologic and some human data suggesting chloride load itself can drive renal vasoconstriction. She is young with normal baseline kidneys and is about to receive a genuinely large volume — if the balanced-versus-saline question is close at the population level, a young, previously healthy patient facing a large total volume is a reasonable place to take the mechanistically favored option rather than treat the choice as arbitrary.
Agreeing with the critical care physician that BaSICS and PLUS complicate SMART's confidence — but complicated confidence is not the same as no reason to choose, and where reasonable equipoise exists, the physiologic argument still points one direction.
Agreed: balanced crystalloid (lactated Ringer's) used for the remainder of her resuscitation, with the first liter of saline already given left as-is rather than treated as a mistake to correct.
Not agreed: how strongly the evidence actually supports this choice at the population level. The critical care physician's read — that BaSICS and PLUS leave this genuinely unsettled — was accepted by both other voices as accurate, and the switch to balanced fluid was made on the nephrologist's narrower, patient-specific mechanistic argument rather than on a claim that the trial evidence itself had settled the question.